BridgeMD
New treatment option for ERAS
Official title The Effect of Perioperative Transcutaneous Electrical Acupoint Stimulation Combined With Traditional Chinese Medicine on Gastrointestinal Function Recovery in Patients Undergoing Abdominal Surgery
ClinicalTrials.gov ID: NCT07081802
What this study is testing
What is Da Jian Zhong Tang (Zanthoxylum, Ginger, Ginseng, Maltose)?
Da Jian Zhong Tang (Zanthoxylum, Ginger, Ginseng, Maltose) is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for eras.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Protocol Summary Project Name:Effect of Perioperative TEAS Combined with TCM on Gastrointestinal Function Recovery in Abdominal Surgery Patients Research Objective:To evaluate the impact of perioperative TEAS combined with TCM on postoperative gastrointestinal function, pain, adverse reactions, hospital stay, and complications, as well as its safety, aiming to enrich the ERAS and prehabilitation theory and promote the integration of TCM in surgical practice. Research Design:Prospective, randomized, open-label trial involving 148 abdominal surgery patients (Grade IV surgeries) randomly assigned 1:1 to the experimental group (TCM + TEAS + prehabilitation + ERAS) or the control group (prehabilitation + ERAS).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients aged \>18 years with no severe preoperative gastrointestinal dysfunction (e.g., no chronic gastrointestinal diseases such as long-term...
- Scheduled abdominal Grade IV surgeries (limited to liver, gallbladder, pancreas, stomach, or intestinal procedures) performed via open or...
- Preoperative American Society of Anesthesiologists (ASA) Physical Status Classification of I-III.
- Patients and their families fully understand the study's purpose, methods, potential risks/benefits, and provide signed informed consent.
You likely can't join if
- Comorbid severe systemic diseases.
- Local skin abnormalities at acupoints (e.g.,broken skin, infection, allergies, or scarring).
- Preoperative long-term use (\>1 month) of gastrointestinal motility-affecting drugs (e.g., mosapride, domperidone) that cannot be discontinued, or...
- Psychiatric disorders or cognitive impairment rendering patients unable to comply with the study. Elimination Criteria:
- Non-compliance with treatment protocols (e.g., receiving \<80% of planned sessions).
- Significant missing data.
See the full eligibility criteria
- Patients aged \>18 years with no severe preoperative gastrointestinal dysfunction (e.g., no chronic gastrointestinal diseases such as long-term constipation or diarrhea).
- Scheduled abdominal Grade IV surgeries (limited to liver, gallbladder, pancreas, stomach, or intestinal procedures) performed via open or laparoscopic approach.
- Preoperative American Society of Anesthesiologists (ASA) Physical Status Classification of I-III.
- Patients and their families fully understand the study's purpose, methods, potential risks/benefits, and provide signed informed consent.
- Comorbid severe systemic diseases.
- Local skin abnormalities at acupoints (e.g.,broken skin, infection, allergies, or scarring).
- Preoperative long-term use (\>1 month) of gastrointestinal motility-affecting drugs (e.g., mosapride, domperidone) that cannot be discontinued, or allergies to TCM components/electrode materials.
- Psychiatric disorders or cognitive impairment rendering patients unable to comply with the study. Elimination Criteria:
- Non-compliance with treatment protocols (e.g., receiving \<80% of planned sessions).
- Significant missing data.
- Occurrence of severe adverse events unrelated to the study intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.